Can we start antiplatelet therapy in a patient with a history of hemorrhagic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: November 20, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the long-term antiplatelet plan for a 73-year-old female with a history of Superior Mesenteric Artery (SMA) thrombosis, Non-ST-Elevation Myocardial Infarction (NSTEMI), Factor V Leiden mutation, Atrial Fibrillation (AF), previous ST-Elevation Myocardial Infarction (STEMI) with stent placement, currently on Heparin infusion being bridged to Warfarin, Aspirin, and Triglyceride-lowering medication (Triglecor), 10 days post-NSTEMI?

What should be the antiplatelet/anticoagulant strategy after hospital discharge for an elderly patient with ischemic dilated cardiomyopathy (IDC) and a history of ischemic stroke in the anterior inferior cerebellar area (AICA)?

When to start anticoagulation (blood thinner) therapy in a stroke patient?

What is the safest antiplatelet regimen for a patient with a recent ischemic stroke who also has a gastric ulcer?

Should a 70-year-old female patient on Clopidogrel (Plavix) and Aspirin after an endarterectomy for internal carotid stenosis discontinue any antiplatelet therapy due to post-menopausal bleeding?

Will the regulatory body assign a generic name to chemical A and allow other pharmaceutical companies to manufacture it once it's approved for commercial use?

How do you differentiate and manage SIADH (Syndrome of Inappropriate Antidiuretic Hormone) versus cerebral salt wasting?

What is the comparison between Myrbetriq (mirabegron) and Gemtesa (vibegron) for treating overactive bladder symptoms?

What is the recommended duration of treatment for unknown bacteria?

What is the smallest amber glass bottle size available from compounding facilities for a liquid medication, specifically for Mast Cell Activation Syndrome (MCAS), to minimize adverse reactions and accommodate a minimal dose of only a few drops?

How is asymptomatic bacteriuria identified in urinalysis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.